These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System. Banik S; Mansour AA; Suresh RV; Wykoff-Clary S; Malik M; McCormick AA; Bakshi CS PLoS One; 2015; 10(6):e0130858. PubMed ID: 26098553 [TBL] [Abstract][Full Text] [Related]
23. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain. Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558 [TBL] [Abstract][Full Text] [Related]
24. A quantitative antibody response of man to infection or vaccination with Pasteurella tularensis. ALEXANDER MM J Exp Med; 1950 Jul; 92(1):51-7. PubMed ID: 15422097 [TBL] [Abstract][Full Text] [Related]
25. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells. Griffin AJ; Crane DD; Wehrly TD; Bosio CM Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207 [TBL] [Abstract][Full Text] [Related]
26. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge. Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555 [TBL] [Abstract][Full Text] [Related]
27. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. Burke DS J Infect Dis; 1977 Jan; 135(1):55-60. PubMed ID: 833449 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers. Waag DM; Sandström G; England MJ; Williams JC FEMS Immunol Med Microbiol; 1996 Mar; 13(3):205-9. PubMed ID: 8861030 [TBL] [Abstract][Full Text] [Related]
29. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Green M; Choules G; Rogers D; Titball RW Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452 [TBL] [Abstract][Full Text] [Related]
31. Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensis. O'Malley KJ; Bowling JD; Barry EM; Hazlett KRO; Reed DS Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31085702 [TBL] [Abstract][Full Text] [Related]
32. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination. Fuller CL; Brittingham KC; Porter MW; Hepburn MJ; Petitt PL; Pittman PR; Bavari S Mol Immunol; 2007 May; 44(12):3173-84. PubMed ID: 17349694 [TBL] [Abstract][Full Text] [Related]
33. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria. Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853 [TBL] [Abstract][Full Text] [Related]
34. Mouse model of oral infection with virulent type A Francisella tularensis. KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058 [TBL] [Abstract][Full Text] [Related]
35. EXPERIMENTAL VIABLE VACCINE AGAINST PULMONARY COCCIDIOIDOMYCOSIS IN MONKEYS. CONVERSE JL; CASTLEBERRY MW; SNYDER EM J Bacteriol; 1963 Nov; 86(5):1041-51. PubMed ID: 14080770 [TBL] [Abstract][Full Text] [Related]
36. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison. Rohmer L; Brittnacher M; Svensson K; Buckley D; Haugen E; Zhou Y; Chang J; Levy R; Hayden H; Forsman M; Olson M; Johansson A; Kaul R; Miller SI Infect Immun; 2006 Dec; 74(12):6895-906. PubMed ID: 17000723 [TBL] [Abstract][Full Text] [Related]
37. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631 [TBL] [Abstract][Full Text] [Related]
38. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance. Anthony LS; Kongshavn PA Microb Pathog; 1987 Jan; 2(1):3-14. PubMed ID: 3507552 [TBL] [Abstract][Full Text] [Related]
39. Characterization of a wild-type strain of Francisella tularensis isolated from a cat. Inzana TJ; Glindemann GE; Snider G; Gardner S; Crofton L; Byrne B; Harper J J Vet Diagn Invest; 2004 Sep; 16(5):374-81. PubMed ID: 15460318 [TBL] [Abstract][Full Text] [Related]
40. Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis. Waag DM; McKee KT; Sandstrom G; Pratt LL; Bolt CR; England MJ; Nelson GO; Williams JC Clin Diagn Lab Immunol; 1995 Mar; 2(2):143-8. PubMed ID: 7697521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]